Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: clinical experience from an expanded access study in the United States

SK Pal, J Hoffman-Censits, H Zheng, C Kaiser… - European Urology, 2018 - Elsevier
Background Atezolizumab (anti–programmed death-ligand 1) was approved in the USA,
Europe, and elsewhere for treatment-naive and platinum-treated locally …
被引用次数：24 相关文章

Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States

SK Pal, J Hoffman-Censits, H Zheng… - European …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Atezolizumab (anti-programmed death-ligand 1) was approved in the USA,
Europe, and elsewhere for treatment-naive and platinum-treated locally …

Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States

SK Pal, J Hoffman-Censits, H Zheng… - European …, 2018 - pure.johnshopkins.edu
Background: Atezolizumab (anti–programmed death-ligand 1) was approved in the USA,
Europe, and elsewhere for treatment-naive and platinum-treated locally …

[引用][C] Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United …

SK Pal, J Hoffman-Censits, H Zheng, C Kaiser… - European Urology, 2018 - cir.nii.ac.jp
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical
Experience from an Expanded Access Study in the United States | CiNii Research CiNii 国立 …

Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States.

SK Pal, J Hoffman-Censits, H Zheng, C Kaiser… - European …, 2018 - europepmc.org
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical
Experience from an Expanded Access Study in the United States. - Abstract - Europe PMC Sign …